Patent · US Active

Collagen hydrolysate for use with skin disorders and intestinal disorders

US12138297B2 · kind B2 · utility

0Cited by

2References

15Claims

0Family size

Assignee

GELITA AG · DE

Inventors

Stephan Hausmanns · Heidelberg, DE
Steffen Oesser · Glücksburg, DE
Franziska Dolle · Eberbach, DE
Hans-Ulrich Frech · Weinheim, DE

Key dates

Filing date	Jun 17, 2021
Grant date	Nov 12, 2024
Priority date	—
Expiry date	Jan 10, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA23V2002/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to collagen hydrolysate for use as an active substance in the treatment of inflammatory skin disorders and intestinal disorders and/or skin disorders and intestinal disorders accompanied by inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.